Showing 1 - 6 results of 6 for search 'Yoshiyuki YAMAGUCHI', query time: 0.03s Refine Results
  1. 1
    Long‐term (>5‐year) survivors among unresectable or metastatic cancer patients treated with zoledronate‐activated killer cells: Seven case reports

    Long‐term (>5‐year) survivors among unresectable or metastatic cancer patients treated with zoledronate‐activated killer cells: Seven case reports by Yoshiyuki Yamaguchi

    Published 2022-11-01
    Get full text
    Article
  2. 2
    Experimental verification of externally pressurized gas journal bearings with asymmetric gas supply (Supply gas pressure control operation using a small size test rig)

    Experimental verification of externally pressurized gas journal bearings with asymmetric gas supply (Supply gas pressure control operation using a small size test rig) by Tomohiko ISE, Kazuya IMANISHI, Toshihiko ASAMI, Takahiro TOKUMIYA, Naoyuki TAKADA, Fumiyoshi KIMURA, Yoshiyuki YAMAGUCHI

    Published 2014-09-01
    Get full text
    Article
  3. 3
    Nrf2 gene mutation and single nucleotide polymorphism rs6721961 of the Nrf2 promoter region in renal cell cancer

    Nrf2 gene mutation and single nucleotide polymorphism rs6721961 of the Nrf2 promoter region in renal cell cancer by Yoshiyuki Yamaguchi, Takao Kamai, Satoru Higashi, Satoshi Murakami, Kyoko Arai, Hiromichi Shirataki, Ken-Ichiro Yoshida

    Published 2019-11-01
    Get full text
    Article
  4. 4
    Evaluation of pancreatic cancer cell migration with multiple parameters in vitro by using an optical real-time cell mobility assay device

    Evaluation of pancreatic cancer cell migration with multiple parameters in vitro by using an optical real-time cell mobility assay device by Akira Yamauchi, Masahiro Yamamura, Naoki Katase, Masumi Itadani, Naoko Okada, Kayoko Kobiki, Masafumi Nakamura, Yoshiyuki Yamaguchi, Futoshi Kuribayashi

    Published 2017-03-01
    Get full text
    Article
  5. 5
    Contrasting Effects of the Cytotoxic Anticancer Drug Gemcitabine and the EGFR Tyrosine Kinase Inhibitor Gefitinib on NK Cell-Mediated Cytotoxicity via Regulation of NKG2D Ligand in Non-Small-Cell Lung Cancer Cells.

    Contrasting Effects of the Cytotoxic Anticancer Drug Gemcitabine and the EGFR Tyrosine Kinase Inhibitor Gefitinib on NK Cell-Mediated Cytotoxicity via Regulation of NKG2D Ligand in... by Riki Okita, Diana Wolf, Koichiro Yasuda, Ai Maeda, Takuro Yukawa, Shinsuke Saisho, Katsuhiko Shimizu, Yoshiyuki Yamaguchi, Mikio Oka, Eiichi Nakayama, Andreas Lundqvist, Rolf Kiessling, Barbara Seliger, Masao Nakata

    Published 2015-01-01
    Get full text
    Article
  6. 6
    The relationship between peripheral neuropathy and efficacy in second-line chemotherapy for unresectable advanced gastric cancer: a prospective observational multicenter study protocol (IVY)

    The relationship between peripheral neuropathy and efficacy in second-line chemotherapy for unresectable advanced gastric cancer: a prospective observational multicenter study prot... by Hiroaki Tanioka, Takeshi Nagasaka, Futoshi Uno, Masafumi Inoue, Hiroyuki Okita, Yosuke Katata, Hiromitsu Kanzaki, Hidekazu Kuramochi, Hironaga Satake, Yoshiaki Shindo, Akira Doi, Jyunichiro Nasu, Haruhiro Yamashita, Yoshiyuki Yamaguchi

    Published 2019-10-01
    Get full text
    Article

Search Tools: